This weekend only, get a Marketplace zip–up hoodie when you donate $8/month. Don’t wait — this offer ends at midnight Sunday!
TEXT OF STORY
SCOTT JAGOW: Smokers wanting to quit? Here’s something else to try: a new pill from Pfizer, called Varenicline.
Today, the Journal of the American Medical Association releases three studies about it. Now, the studies were paid for by Pfizer, but they do suggest it’s easiest to quit smoking after taking this pill for a year.
Analyst Les Funtleyder says considering how many people fail to quit smoking, Pfizer could have a $400 million drug here.
LES FUNTLEYDER: “In general that’s not considered a blockbuster, but it’s a nice size drug, and given that Pfizer needs to replace numerous products that are going off patent in its pipeline, it’ll be helpful.”
The FDA has already approved Varenicline.
A lot of smokers buy whitening toothpaste I’m sure. Might want to check out the latest Consumer Reports. They tested 41 brands of toothpaste and found no real link between claims of whitening and actual stain-removing.
Only one brand stood out as a stain-remover: Ultrabrite All-in-One Advanced Whitening.
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.